Form 4: Lemaitre Vascular Executive Acquires Shares and Options in Recent Transaction

David B. Roberts, President and Director of Lemaitre Vascular, acquired 1,335 shares of common stock and 7,662 stock options on December 6, 2024.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular, reported a transaction on December 6, 2024.
• He acquired 1,335 shares of common stock at a price of $0, resulting in a total of 15,355 shares beneficially owned.
• Additionally, he acquired 7,662 stock options with an exercise price of $101.12.
• These options vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the following three years.
• The restricted stock units also vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the following three years.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of insider transactions, which is neither particularly positive nor negative. The acquisition of shares and options by an executive could be seen as a positive sign of confidence, but it is a standard practice.

Positives

• The acquisition of shares and options by a key executive could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for company insiders who have made transactions in their company's stock. It is common for executives to receive stock options and restricted stock units as part of their compensation.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation across the medical device industry.
• Companies like Medtronic, Boston Scientific, and Abbott also use similar equity-based compensation plans to align executive interests with shareholder value.
• The vesting schedules described are typical for these types of grants, usually over a 3-4 year period.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates confidence from a key executive.

Key Dates

Keywords

Lemaitre Vascular, insider trading, stock options, share acquisition, David B. Roberts, executive compensation, restricted stock units